Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study).
Hiroshi NomotoChiho Oba-YamamotoYuka TakahashiJun TakeuchiSo NagaiHiroki YokoyamaShinji TanedaYoshio KuriharaShin AokiHiraku KamedaKyu Yong ChoAkinobu NakamuraTatsuya AtsumiHideaki MiyoshiPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
UMIN000042369 in the University Hospital Medical Information Network (UMIN); jRCT1011200008 in the Japan Registry of Clinical Trials (jRCT); pre-results.